Patient]. A 66-year-old man was first evaluated in the Renal Clinic of the New England Medical Center (NEMC) at age 53. At age 9, he developed periorbital and peripheral edema, gross hematuria, cylindruria, and proteinuria. He was told he had acute glomerulonephritis and was confined to bed for one month; the edema and hematuria resolved. He remained asymptomatic for the next four decades although urinalyses performed during Army and insurance examinations consistently revealed trace to I + protein.
During the next 6 months, the serum creatinine remained unchanged and hematuria disappeared. Retinopathy and hypertension resolved, and antihypertensive therapy was withdrawn. Urinary protein excretion fell to I g daily.
Nine years ago, hypertension reappeared (the blood pressure was 150/115 mm Hg), and treatment with alpha-methyldopa was reinstituted. A symptomatic proteus urinary tract infection 7 years ago was treated with sulfonamides. An intravenous pyelogram was normal (kidneys were 14.2 cm), the serum creatinine was 0.8 mg/dl, and proteinuria was unchanged. Since then, urinary protein excretion has gradually declined to 200 mg daily. Alpha-methyldopa was discontinued because of fatigue. She takes 50 mg of hydrochlorothiazide daily and 40 mg of propranolol 4 times daily, and her blood pressure remains relatively well controlled. Six months ago, physical examination was normal. The BUN was 12 mg/dl and the serum creatinine was 0.9 mg/dI. Urinalysis revealed I + proteinuria; no cells or casts were found in the urinary sediment. Discussion DR. DAVID S. BALDWIN (Professor of Medicine, New York University School of Medicine, New York, New York): The first patient's story began when, at 9 years of age, he had an illness labeled "acute glomerulonephritis." The early features of the disease resolved in one month, but proteinuria persisted. He developed hypertension 44 years later at age 53 years, and by the time he was 66 years old-57 years after the apparent onset of his renal disease-advanced renal failure necessitated the use of hemodialysis. Is this clinical progression consistent with the long-term course of acute glomerulonephritis, or should we scrutinize the clinical features of this patient's disease to determine whether another diagnosis would fit better?
The term acute glomerulonephritis implies the presence of a disease characterized morphologically by diffuse endocapillary proliferation in glomeruli, often with exudative features, and occasionally with extracapillary proliferation as well. These are the histologic features of immune complex-mediated, postinfectious glomerulonephritis, of which poststreptococcal glomerulonephritis (PSGN) is the prototype. Let us examine the course of this patient's disease as compared with 185 patients with sporadic (that is, nonepidemic) PSGN observed at Bellevue Hospital, in whom a poststreptococcal cause was established in all, and in whom the diagnosis was confirmed by renal biopsy in two thirds [1] . Most of the patients in this series were adults; all were hospitalized at onset.
We are given no information relative to the possible cause of this patient's disease, so one cannot use failure to document an antecedent group-A, 3-hemolytic streptococcus infection to dismiss the diagnosis of PSGN. The early features that were used to establish the clinical diagnosis of "acute nephritis" included edema, gross hematuria, and proteinuria, Having no further details, I will not dispute the likelihood that the clinical features at least were compatible with acute glomerulonephritis. What about the patient's subsequent clinical course? Persistent proteinuria was observed in about one-half of our patients with PSGN, but it has been described less often by other observers, especially in series of children, and only rarely in reports of epidemic PSGN. The recurrence of hypertension many years after the onset of PSGN also is compatible with our experience. The development of uremia was quite unusual in our patients, although it did occur in a few. Persistent proteinuria, moderate hypertension, and minimal impairment of renal function were common. In our study, which began in 1960 and includes new patients added throughout the subsequent 20 years, 10 of 185 patients now have advanced renal failure [2] .
The only feature of this patient's clinical course that does not appear compatible with postinfectious diffuse proliferative gbmerulonephritis is the recurrence of edema many years after the onset of the disease. In PSGN, edema typically occurs at onset, may at times be associated with the nephrotic syndrome, and subsides within days to weeks in association with remission of the other initial manifestations in well over 90% of patients studied. Edema may persist in the unusual patient in whom severe, active renal disease continues and in whom progression to irreversible renal failure occurs shortly after the onset of PSGN or within one year or so. However, when the initial features remit, as they typically do, neither edema nor the nephrotic syndrome recurs except in those rare instances in which the patient experiences a second episode of acute nephritis. Of course, edema also can reappear in the terminal stage of renal failure as a manifestation of the patient's marked functional impairment and limited ability to handle salt and water.
What other possibilities should we consider in the patient whose early clinical features were compatible with acute nephritis? Do any other glomerular diseases better explain this patient's subsequent course than does postinfectious, diffuse, proliferative glomerulonephritis? When this patient first became ill, Berger's IgA nephropathy had not yet been described. Yet one can easily understand how patients with gross hematuna, whom we now know might possibly have IgA nephropathy or non-IgA focal glomerulonephritis, might have been thought to have "acute gbomerubonephritis." The occurrence of edema at onset, however, is rare (although not unheard of) in IgA nephropathy. As our increasing experience with Berger's nephropathy has taught us, the patient's slowly progressive clinical course would be compatible with this diagnosis, but the fact that the later development of edema and heavy proteinuria was not associated with progression of renal failure over a relatively short period of time virtually eliminates Berger's nephropathy from the differential diagnosis. Another morphologic entity that is occasionally marked by symptoms of "acute nephritis" at onset is mesangiocapillary glomerulonephritis (MCGN). We do not know the serum complement level, which might be helpful in this differential diagnosis if persistent or intermittent depression of C3 beyond the acute stage had occurred. In the course of MCGN, however, the nephrotic syndrome is common, especially when the patient is becoming uremic. I believe this patient's protracted clinical course and particularly the absence of the nephrotic syndrome definitely rule out the diagnosis of MCGN. Finally, extracapillary proliferative (or crescentic) glomerulonephritis can have an acute nephritic" onset, but the diagnosis is highly unlikely in this patient; he was much too young, and his disease was too indolent. Actually, the spectrum of crescentic glomerulonephritis does include patients whose course is snot so rapidly progressive," but a mild and brief acute episode followed by slow progression over decades is not compatible with this diagnosis.
Diffuse endocapillary proliferative glomerulonephritis, therefore, is probably the corrrect morphologic diagnosis. Slow progression to glomerular sclerosis and end-stage renal failure occurred even though the initial episode was mild and minimal proteinuria was the only manifestation for more than 40 years.
We know from similar observations in patients with documented PSGN that, during the years following the acute stage, proliferation is no longer present in glomeruli, and immunopathologic evidence of immune-complex disease is no longer demonstrable. Yet the disease progresses. In a moment we will consider possible nonimmunologic mechanisms by which gbmerulonephritis might progress in such patients. The second patient described today provides a fascinating contrast with the first. In this woman, PSGN was documented by bacteriologic, clinical, and morphologic criteria at age 44 years. Although her disease was severe enough to necessitate dialysis during the initial 3 weeks, her course has been relatively benign over the subsequent 12 years of followup. On the other hand, our first patient, who seemed to have mild acute nephritis, ultimately developed uremia. For more than 4 decades, however, he showed only minimal evidence of glomerular disease, and his clinical course was very similar to the experience of our second patient during the 12 years since her initial episode. In relating the severity of disease at onset in PSGN to the eventual outcome, we have observed a correlation between the severity of initial clinical and morphologic manifestations and the presence of hypertension, proteinuria, renal functional impairment, and glomerular sclerosis 2 or more years from onset [1] . Patients who had mild disease initially were not protected from developing chronic disease, however. It is even more interesting that most of the patients who eventually became uremic experienced periods of several years with only minor manifestations of disease: little or no proteinuria, normal blood pressure or mild hypertension, and creatinine clearance in the normal range [2] .
The classic episode of acute PSGN in the second patient occurred in concert with acute rheumatic fever and erythema nodosum following a documented group-A, -hemo1ytic streptococcus pharyngitis. Not only was the infectious cause established, but in addition a renal biopsy showed the typical findings of diffuse endocapillary proliferative glomerubonephritis, and serum complement was decreased. The patient, who became anuric at the onset and remained so for 3 weeks, required peritoneal dialysis. With PSGN of this severity, one would expect the presence of extracapillary as well as endocapillary proliferation, but this finding was not described.
Although years of follow-up, the patient's hypertension has been controlled with medication, she has had minimal but persistent proteinuria, and she has maintained normal renal function.
Despite the severity of the disease at onset, this patient's course has been relatively benign thus far. The development of glomerular sclerosis and the reappearance and persistence of hypertension and proteinuria indicate, however, that irreversible damage accompanied the acute episode. The features of the long-term course in this patient are typical of those we have observed in the majority of our adult patients who have been followed for 10 years or more [3] . In many, the evidence of progressive disease is lacking, but hypertension and proteinuria, both sequelae of the acute attack, persist. In others, manifestations that remitted early have reappeared, and slow progression has occurred. A few have advanced to end-stage renal failure. In today's first patient, 44 years elapsed between the onset of the disease and terminal uremia. The second patient, whose disease began when she was in her 40s and who has evidence of chronic disease 12 years later, can be expected to have a slowly progressive course, but she probably never will have clinically significant renal insufficiency.
The importance of these two case histories is not that they merely teach us that PSGN can insidiously lead to uremia over many years after the early features of the disease subside. After all, PSGN is now an uncommon disease, as is acute rheumatic fever, the other sequel of 3-hemolytic streptococcal infection. But these observations on the continued progression of PSGN after the initial immune process has subsided have provided the stimulus for us to speculate on what factors, other than immune mechanisms, might be capable of producing gbomerular damage. It seems highly likely to me that if nonimmunobogic mechanisms of glomerular injury are responsible for progression in PSGN, these mechanisms probably play a role in other glomerular diseases as well. I'd now like to turn to a discussion of these mechanisms. An immunopathogenetic mechanism-immune complex or antiglomerular basement membrane antibody-is held responsible for most forms of primary glomerular disease in humans.
Although immunologic mechanisms and the mediators of glomerular damage that they induce might form the basis for initiating most glomerular diseases, certain clinical observations and experimental data suggest that the progression of these diseases is influenced by several nonimmunobogic factors.
Intrarenal vascular disease. Sclerosis of arterioles and prearterioles, a common finding in advanced glomerular disease, has long been recognized at postmortem examination and conventionally has been interpreted as an effect of hypertension.
Researchers thus have assumed that ischemic glomerular sclerosis resulting from intrarenal vascular disease contributes to the progression of renal failure during the hypertensive stage of glomerular disease and, consequently, the importance of controt of blood pressure has been stressed [4] [5] [6] [7] [8] .
Matignant hypertension can occur with glomerulonephritis, and the associated necrotizing arteriolitis of the renal vessels might justifiably be attributed to the marked elevation of diastotic blood pressure. The frequent occurrence of intrarenal vascutar sclerosis early in the course of glomerulonephritis prior to the advent of hypertension, or with only mild elevation of blood pressure, however, suggests a particular susceptibility of the renal arterioles to the effects of hypertension in glomerulonephritis, or perhaps indicates that vascular disease even might be a primary feature of the disease rather than a secondary manifestation of hypertension.
We have studied biopsies in patients in intermediate stages of poststreptococcal glomerulonephritis [9] , and in Berger's IgA nephropathy [10] , when renal function is normal or minimally impaired and hypertension is mild or absent. The results demonstrate a high incidence of arteriolar and prearteriolar sclerosis. Similar observations have been made in a variety of other glomerular diseases in which vascular sclerosis exceeded the damage that one would anticipate for the age of the patient and the duration and severity of hypertension. Kincaid-Smith reported that the incidence of renal arterial and arteriolar lesions ranged from 54% to 82% in normotensive patients under age 40 years who had various forms of glomerulonephritis [11] ( Table 2 ).
In our studies, vascular changes closely correlated with gtomerutar sclerosis and suggested to us a cause-and-effect relationship in which ischemia was responsible for glomerular damage. As shown in Figure 1 , 21 renal biopsy specimens from patients with poststreptococcal gtomerulonephritis were judged to have a significantly greater frequency of gtomerular sclerosis than did specimens from age-matched controls; 17 ofthe 21 also showed arteriolar sclerosis. In 19 specimens unaffected by glomerular sclerosis, only 5 showed arteriolar sclerosis. A similar correlation was demonstrated for Berger's IgA nephropathy. Sixteen of 20 specimens with significantly more glomerular sclerosis than expected showed arteriolar sclerosis as well; of 26 specimens without glomerular sclerosis, only 4 had arteriolar sclerosis.
The frequent presence of ischemic or "collapse-type" sclerosis of the glomeruli rather than disorganization of glomerular structure seemed to lend further support to a causative role for vascular sclerosis in the progression of these glomerular diseases [9, 10] . Such an hypothesis is especially attractive for our understanding of PSGN in which immune damage almost certainly abates within one year or so from onset, as evidenced by the usual absence of immunoglobulins in glomeruli beyond this time [12] . Under these circumstances, progressive gbomerutar sclerosis requires the operation of nonimmunologic mechanisms, and the clinical and pathologic evidence just cited supports the theory that vascular disease and resultant ischemia cause progressive renal damage. Recent hemodynamic and morphologic observations in the remnant kidney and in experimental nephritis suggest, however, that adaptive increases in perfusion following nephron loss or injury can be responsible for further glomerular damage. The emphasis thus has shifted away from ischemic glomerular sclerosis to hyperperfusion as a possible mechanism for both vascular and glomerular injury in chronic glomerulonephritis.
Adaptive changes in glomerular hemodynamics. Studies in experimental animals show that removal of about five-sixths of renal mass results in proteinuria, hypertension, progressive renal failure, and advanced glomerular sclerosis [13- 151. This finding suggests that adaptive alterations in renal hemodynamics, or other factors related to reduced renal mass and its biochemical consequences, can cause further renal damage. Such mechanisms could contribute to ongoing parenchymal destruction in patients with renal disease regardless of the initial cause of reduced renal parenchymal mass.
Brenner and coworkers, in studies of glomerular hemodynamics in the remnant kidney, have demonstrated adaptive increments in glomerular blood flow and single-nephron GFR [16] [17] [18] (Table 3) . Despite only a minimal increase in systemic arterial pressure, transcapillary hydraulic pressure significantly increased as a result of elevated glomerular capillary hydraulic pressure. Adaptive reductions in afferent arteriolar resistance must account for the increased transmission of systemic pres- sure to the glomerular capillaries and for the increments in glomerular perfusion. The authors suggest that these adaptive changes might have an adverse effect on renal function by accelerating glomerular sclerosis in the remaining glomeruli. The alterations in glomerular hemodynamics that occur in the remnant kidney resemble those that Azar et a! have described in one-kidney, "post-salt" hypertension, in which glomerular sclerosis was associated with reduced arteriolar resistance and increases in transcapillary pressure, glomerular blood flow, and single-nephron GFR [19] .
Maddox et al have shown that Munich-Wistar rats with recently induced, mild to moderate nephrotoxic serum nephritis (NSN) maintain normal glomerular plasma flow rates and single-nephron GFR despite morphologic evidence of widespread glomerular injury [20] . Transcapillary hydraulic pressure was considerably elevated due to increased glomerular capillary pressure, and single-nephron GFR failed to increase only because of a reduction in the ultrafiltration coefficient; the authors attribute these results to the loss of patent capillaries in NSN. Allison, Wilson, and Gottschalk found that these same pressures remain elevated in rats with chronic glomerulonephritis [21] . Thus, adaptive decreases in afferent arteriolar resistance must occur in the course of glomerulonephritis as they do in reduced renal mass, thereby exposing the glomeruli to increased intracapillary pressures.
Further evidence of secondary glomerular damage in the remnant kidney has been provided by Olson et al, who found that endothelial and epithelial cell abnormalities occur along with altered charge and size-selective properties of the glomerular wall [221. These authors showed a reduction in the chargeselective barrier to filtration in the remnant kidney by demonstrating that the fractional clearance of anionic horseradish peroxidase was increased, whereas that of the cationic form was decreased. Fractional clearance of low-molecular-weight neutral dextrans was not affected, but the clearance of highermolecular-weight neutral dextrans was practically doubled; these changes suggested impairment of glomerular size selectively as well.
Utilizing cationic probe molecules, Shea, Raskova, and Morrison showed that proteinuria in the subtotally nephrectomized rat was not accompanied by changes in the ultrastructural distribution of anionic sites in the glomerular basement membrane [23] . These investigators have suggested, rather, that proteinuria in the remnant kidney results from sustained rises in glomerular capillary pressure that, in turn, cause an increase in pore size.
Direct effect of hypertension on glomerular structure and function. The occlusive effect of hypertension on the renal arterioles and prearterioles is generally accepted as the mechanism by which hypertension aggravates the course of glomerulonephritis. Vascular narrowing is thought to accelerate glomerular sclerosis through ischemia. The "vicious cycle in Bright's disease" as proposed by Wilson and Byrom alludes to this mechanism [24] . However, a number of recent studies in experimental hypertension and in hypertension superimposed on a variety of glomerular diseases provide evidence that glomerular damage might be produced directly by hypertension rather than secondarily through ischemia resulting from occlusive small vessel alterations. Knowlton et al, in 1946, administered DOCA to rats with nephrotoxic serum nephritis and produced severe hypertension and a worsening of the glomerular disease; the authors reported no change in proteinuria [25] . In a series of studies in which NSN was induced in animals with preexisting hypertension, Masuyama and associates observed increased severity of hypertension and more persistent proliferative and sclerotic changes in glomeruli; vascular alterations were not described [26] [27] [28] . Motoki et al produced hypertension with DOCA and salt-loading in the unilaterally nephrectomized rat with NSN and noted increased glomerular proliferation and sclerosis [29] .
Teodoru, Saifer, and Frankel showed that more rabbits with NSN develop severe glomerulonephritis and die of uremia if they have been unilaterally nephrectomized or salt loaded beforehand [30] . Blood pressure measurements were not performed in this study, but one can presume that the salt-loaded rabbits were hypertensive. Increased proteinuria and proliferative-sclerotic glomerular changes were reported by Tikkanen and associates, who superimposed DOCA-salt hypertension on autologous immune glomerulonephritis (Heymann nephritis) in the rat; vascular sclerosis and necrosis occurred infrequently in this model [31] . Using DOCA-salt hypertension in heterologous immune glomerulonephritis (passive Heymann nephritis), Iverson and Ofstad noted more marked glomerular basement membrane thickening, greater proteinuna, and a shortened life span of the experimental animals [32] . In a study of steroid-induced hypertension in the uninephrectomized rat, Hill and Heptinstall first suggested in 1968 that failure of adequate arteriolar constriction rather than excessive narrowing was responsible for the hypertensive lesions that developed in insufficiently hypertrophied vessels and their "unprotected" glomeruli [33] . suggested that hypertension might directly damage the glomerular capillary [34] . The vascular and glomerular damage described by these authors probably was attributable to malignant hypertension, but they introduced a new and important concept-that glomerular vessels are affected directly by hypertension and do not suffer merely as a secondary result of arteriolar narrowing and ischemia. Azar et al, in studies of one-kidney, "post-salt" hypertension in the rat, recently showed proliferation and sclerosis of glomeruli in association with reduced arteriolar resistance and increases in transcapillary pressure, glomerular blood flow, and single-nephron GFR [191. These investigators suggested that adaptive decreases in afferent resistance following uninephrectomy overrode the ability of arterioles to increase their resistance in the presence of superimposed hypertension, thus exposing the glomerular capillaries to damaging increases in hydraulic pressure. In a subsequent study, these authors demonstrated that salt-sensitive rats who develop hypertension with both kidneys intact show similar increases in single-nephron GFR that result from elevated glomerular blood flow and glomerular transcapillary hydraulic pressure [35] . The authors propose that the glomerular lesions in these rats are attributable to high glomerular capillary pressures that occur when hypertension and nephrosclerosis are superimposed on the genetically reduced number of adapted nephrons known to exist in this strain.
In related studies, Mauer and associates examined the effect of hypertension produced by renal artery clipping on streptozotocin-induced diabetes mellitus in the rat. They observed increased mesangial matrix material and heavier deposits of IgG, 1gM, and C3 in the unclipped "diabetic" kidney [36] . Additional evidence for the possible role of glomerular hemodynamic factors in diabetic glomerulosclerosis was adduced by Azar, who demonstrated that glomerular capillary pressure is increased prior to any morphologic changes in rats with shortterm diabetes induced by pancreatectomy [37] . Finally, Hostetter et al recently reported glomerular hyperfiltration in moderately hyperglycemic Munich-Wistar rats made diabetic with streptozotocin [38] . This hyperfiltration resulted from elevations in glomerular plasma flow and increases in transcapillary hydraulic pressure difference.
We have examined the effect of superimposed renal artery clip hypertension (CH) on the clinical and morphologic features of NSN in the Sprague-Dawley rat [39] . Our objective was to determine (1) whether the effects on the renal arterioles of a given elevation in blood pressure were increased in the nephritic animal; and (2) whether the glomerular abnormalities of NSN Fig. 2 . Incidence of glomerular and vascular morphologic lesions in nephrotoxic serum nephritis, in clip hypertension, and in the combina-(ion of nephrotoxic serum nephritis with clip hypertension. The superimposition of clip hypertension (CH) on nephrotoxic serum nephritis (NSN) increased the incidence of glomerular proliferation, tuft necrosis, and sclerosis, and resulted in the appearance of vascular sclerosis (arteriolar medial hypertrophy) in almost every instance.
would be aggravated by concomitant hypertension. To avoid the catastrophic effects of necrotizing vasculitis that would be anticipated with marked elevations in blood pressure and which could obscure differences between hypertension alone and hypertension superimposed on NSN, we selected animals for comparison that had mean systolic blood pressures ranging between 120 and 160 mm Hg. Further, we attempted to induce a mild form of NSN to facilitate the recognition of any magnified effects of superimposed hypertension on the severity of glomerular lesions. Table 4 includes data for all animals sacrificed at 3, 4, and 5 months after application of the renal artery clip, which followed injections of nephrotoxic serum by one month. Data for control animals and those with NSN alone and CH alone are given for comparison. The mean systolic blood pressures in the two hypertensive groups were almost identical; the similarity in heart weight to body weight ratios lends support to the close correspondence in measured blood pressures in the CH and NSN + CH groups. As Table 4 shows, the superimposition of hypertension on NSN markedly increased the level of protein excretion at the time of each monthly sacrifice. The incidence and severity of glomerular and vascular lesions similarly were aggravated by the superimposition of hypertension on NSN (Figs. 2-5 ). Whereas the occurrence of glomerular proliferation and tuft necrosis never exceeded approximately 20% in rats with CH or NSN alone, when CH was combined with NSN, the incidence of these glomerular abnormalities exceeded 80% in the latter stages of the experiment. The incidence and severity of glomerular sclerosis similarly increased in rats with CH superimposed on NSN. Arteriolar medial hypertrophy was not noted in rats with NSN and occurred mildly and only occasionally in rats with CH; the incidence of severe arteriolar sclerosis reached almost 100% when hypertension was combined with NSN.
Our studies demonstrate that the superimposition of hypertension in the rat with NSN markedly aggravates the glomerular abnormalities and induces changes in the renal arterioles that do not occur in NSN alone or in CH alone at comparable levels of systolic blood pressure. The results suggest that the intrarenal vessels in experimental nephritis might be abnormal in a way that renders them more susceptible to the effects of increased intraluminal pressure, even though these vessels appear morphologically unaffected by the disease, The diseased glomerular capillaries might be showing a similar increased susceptibility to damage. On the other hand, one could hypothesize that the glomerulus in experimental nephritis actually is exposed to greater hydraulic pressure and flow than might normally occur at a given systemic pressure. Such increases could be due to adaptive alterations in renal resistance that accompany glomerular disease. The failure of arteriolar constriction to occur in the presence of systemic hypertension could lead to hyperfiltration and resultant acceleration of glomerular proliferation and sclerosis. This afferent arteriolar faiIure" also might be responsible for the markedly increased frequency and severity of small vessel damage that occurs at a given level of systemic pressure when hypertension is combined with glomerulonephritis. Adverse role of dietary protein in experimental nephritis and in a model of renal ablation. Numerous investigators have explored a possible deleterious effect of dietary protein on the course of experimental nephritis and on the progressive renal failure that occurs with subtotal renal ablation. On balance, the available evidence indicates that high protein intake accelerates renal failure in both models. In 1939, Farr and Smadel showed that in rats with NSN given a 5% protein intake, clinical renal disease subsided rapidly and glomerular and tubular injury resolved [40, 41] . By contrast, rats fed a diet containing 40% protein uniformly developed renal failure and died within one year. Postmortem examination revealed progressive scarring and destruction of tubules and glomeruli. Rats fed a basal or mixed-stock diet followed a course that was intermediate between results from the extremes of protein intake. Earlier, Medlar and Blatherwick [42, 43] and Kennedy in b N refers to the number of animals alive at that time.
P < 0.01 for differences between animals on normal diet and phosphate-restricted animals at same time.
1957 [44] had suggested that sclerosis occurring with aging, uninephrectomy, or both could be accelerated by high-protein feeding. Lalich and Allen studied unilaterally nephrectomized rats fed diets containing 30% protein and found excessive proteinuria followed by ultrastructural changes leading to eventual sclerosis of glomeruli [45] . In a recent study, Kleinknecht and associates examined the effects of various protein diets on growth, renal function, and survival in Wistar rats who were subjected to ablation of seven-eighths of their renal mass [46] . A diet containing 37% protein led to anorexia, growth failure, and rapid deterioration of renal function in these rats. Although the content of sodium, phosphate, and calcium also was higher in the high-protein diets, none of the dietary regimens was low in these minerals, so an important, albeit not exclusive, deleterious role for protein was established in these studies.
The mechanism by which high protein intake accelerates glomerular sclerosis in animals with experimental nephritis, with subtotal renal ablation, or with aging has not been elucidated. However, studies by Shannon, Joliffe, and Smith [47] , Van Slyke et al [481, and Pitts [491 in the 1930s might be relevant to this issue. These authors showed that urea clearance, filtration rate, and renal blood flow could be increased two-to threefold in the dog by high-protein feeding. Once again, a possible role for increased glomerular perfusion and hyperfiltration in the causation of sclerosis is suggested. There are as yet no adequate clinical studies in humans that examine the relationship between protein intake and the course of parenchymal renal disease.
Phosphorus restriction and preservation of renal function. Preservation of renal function by phosphorus restriction has been demonstrated in the renal ablation model by Ibels and associates [50] and in nephrotoxic serum nephritis in the rat by Karlinsky [51] . Ibels and colleagues reported prevention of proteinuria, renal calcification, histologic changes, functional deterioration, and death from uremia (Table 5 ). Similar salutary effects were noted in the phosphorus-restricted rat with experimental nephritis. The mechanism by which phosphorus restriction prevents functional deterioration in the remnant or the diseased kidney is not known [52] . One obvious possibility is that dystrophic and metastatic renal calcification in the cauterized remnant is prevented through suppression of secondary hyperparathyroidism and a reduction in calcium-phosphorus product. However, the striking protective effect of phosphorus restriction on the glomerular lesions of nephrotoxic serum nephritis suggests that mechanisms of renal damage other than calcification alone must be involved.
Glomerular sclerosis and aging. The occurrence of proteinuria in the aging male rat has long been recognized [53, 54] . Although this proteinuria rarely gives rise to the nephrotic syndrome, renal lesions closely resembling focal and segmental glomerular sclerosis in humans are common in several species of aging male rats [45, 551. This phenomenon is of interest as a possible model for the investigation of the mechanisms responsible for progressive glomerular injury and sclerosis in human renal diseases. Protein loading accelerates the development of the lesion [42, 43, 45] , whereas low sodium intake prevents both the increasing proteinuria and glomerular sclerosis [56] . Unilateral nephrectomy increases the incidence of glomerular sclerosis in the aging rat, especially when combined with increased dietary protein intake [57] . Recent ultrastructural and immunofluorescent observations have demonstrated increased 1gM deposits in the mesangium as well as progressive glomerular basement membrane and epithelial cell damage associated with nonselective proteinuria [58-601. These studies prompted the hypothesis that focal glomerular sclerosis in the aging rat might result from mesangial overload and dysfunction consequent to a persistent increase in glomerular permeability and proteinuria. By analogy, one can argue that mesangial functional overload and its consequences play a similar role in human glomerular diseases, especially when the hemodynamic consequences of reduced renal mass and hypertension are superimposed on damaged glomerular capillaries.
Age-related glomerular sclerosis also occurs as a phenomenon of aging in humans. Kaplan et al, in a postmortem study, found that the incidence of glomerular sclerosis did not exceed 10% in individuals under 40 years of age [61] . With increasing age, however, the frequency of sclerotic glomeruli reached almost 30%. Kappel and Olsen reported similar findings, that is, a highly significant correlation between age and percentage of sclerotic glomeruli [62] . The weight of total renal and cortical mass decreases to about one-half between the ages of 40 and 80 to 90 years. During the same time span, renal hemodynamics and functional tubular mass decrease by 40% to 50% [63] . Although it is generally held that abiotrophic involutional sclerosis of glomeruli is secondary to vascular sclerosis, McLachlan et al failed to find a significant correlation between vascular changes and glomerular sclerosis in the aging kidney [64] . An understanding of the mechanisms responsible for glomerular involution with aging might provide insights into disease progression.
Aminonucleoside nephrotic syndrome and glomerular sclerosis. A model of chronic renal disease utilizing repeated injections of aminonucleoside, an agent that usually produces a reversible renal lesion when given in a single course, was described by Wilson and associates in 1958 [65] . Others subsequently have investigated the presumed nonimmunologic pathogenesis of this form of renal injury [66] . Most recently, Glasser, Velosa, and Michael reported that an apparent threshold level of protein excretion was essential for the development of focal glomerular sclerosis in this model [67] . Many groups have proposed that in this model of focal sclerosis, irreversible epithelial cell injury is the primary pathogenetic mechanism that leads to eventual glomerular sclerosis as a result of increased protein permeability, deposition of fibrin and related antigens, and protein-aggregate accumulation in the mesangium and subendothelium [68] [69] [70] [71] [72] . "Mesangial overload," the basis for glomerular injury and sclerosis hypothesized in this model, might prove to be one of the nonimmunologic mechanisms responsible for progression of renal disease in humans.
Glomerular sclerosis in reflux nephropathy. Investigations into the progression of renal insufficiency after the surgical correction of reflux nephropathy have disclosed the occurrence of a focal, segmental, sclerosing glomerular lesion that often is associated with heavy proteinuria [73-771. Immunopathologic studies suggest a possible immune mechanism of glomerular damage [78] , but progressive parenchymal damage in this situation might represent still another example of the deleterious effects of adaptation to loss of renal mass on remaining intact nephrons.
Summary. Let me now summarize what these data have taught us. Our long-term observations in poststreptococcal glomerulonephritis and other glomerular diseases suggested that nonimmunologically mediated damage often was related to ischemia secondary to intrarenal vascular sclerosis which, in turn, could be attributed to hypertension. However, a new basis for glomerular obliteration has emerged from physiologic and morphologic studies of reduced renal mass, the aging kidney, post-salt or steroid-induced hypertension, and various forms of hypertension superimposed on experimental nephritis. It appears that nephron loss begets further glomerular damage through adaptive hemodynamic changes that take place in remaining nephrons and that expose the glomerular capillaries to increased flows and hydraulic pressures. When systemic hypertension occurs in conjunction with glomerulonephritis, glomerular damage is further increased, possibly through increased transmission of elevated pressures. One can hypothesize that elevated glomerular pressure and consequent hyperfusion rather than ischemia is the mechanism by which hypertension aggravates glomerulonephritis: a failure of autoregulation in nephrons adapted to disease. The mechanism by which increments in glomerular capillary hydraulic pressure eventually result in sclerosis and obliteration of capillaries is not known, but epithelial cell damage with alterations in permselectivity and resultant mesangial overload and dysfunction might be responsible. The adverse effects of dietary protein and the protective role of phosphorus restriction might operate through similar mechanisms, in which altered glomerular hemodynamics play a key role. and his associates on the model of this lesion that can be produced by chronic administration of aminonucleoside [67, 68] . These studies and the observations on proteinuria and the development of glomerular sclerosis in the aging rat kidney [56] [57] [58] [59] [60] and in the remnant kidney [22] suggest that increased permeability to large molecules may be responsible for glomerular damage. In other words, proteinuria may not be only the passive result of abnormal glomerular capillary permeability; the increased passage of proteins may in itself cause further glomerular damage, possibly through "measangial overload."
This hypothesis revives the old argument as to whether minimal change nephrotic syndrome can evolve into focal segmental glomeruloscierosis. Some patients seem to have minimal change as evidenced by biopsy and by the characteristic response to steroids, but they then become steroid resistant and progress to renal failure. This suggests that proteinuria itself may actually be damaging. Thus, in patients with minimalchange nephrotic syndrome, the goal of inducing a remission may be more important than simply raising serum albumin and ridding the patient of edema. By correcting the defect that allows the protein leak, one acually may be preventing the development of glomerular sclerosis.
DR. HARRINGTON: That is interesting because the data from both the Collaborative Study of the Adult Idiopathic Nephrotic Syndrome [79] and our combined Boston University-Tufts nephrotic syndrome study [80] show a very good correlation between the degree of proteinuria and renal function. Renal function remained normal in all patients with protein excretion of less than 2 g/day.
DR. JORDAN J. COHEN: I gather from your thesis that you would predict that further progression is inevitable once a patient with chronic glomerulonephritis reaches a certain critical level of renal insufficiency. Have you had the experience of seeing patients-as we thought we were seeing in today's first case-with serum creatinine levels of 4 or 5 mgldl for many years who go on to live a normal lifetime and die from other causes? DR. BALDWIN: Rarely, except in the elderly. A serious problem almost certainly exists if a patient with chronic renal disease loses function beyond a certain level, say 50%. We used to say that when glomerulonephritis goes into the hypertensive stage, you can count the years that patient will survive. I think what that really implied was that when the "magic number" of nephrons has been lost and the remaining ones have adapted to this loss, and hypertension is then added that is "unopposed," sclerosis of remaining arterioles and glomeruli is inevitable. The creatinine clearance seems to decrease arithmetically early in the patient's course. Then in the last 3 or 4 years it declines more rapidly. I think this change occurs because adapted nephrons and their arterioles are highly susceptible to the effects of hypertension. I don't wish to appear dogmatic in this regard. The reverse also occurs: loss of nephrons itself causes the hypertension. We may have to invoke the old "vicious cycle" here. Who can say which comes first? I think that the reason we were able to show what we did was because our model of experimental hypertension employed a renal artery clip, which does more than just produce hypertension. Clipping the kidney, and essentially ablating it functionally, increases the work of the remaining kidney: not only is the kidney nephritic and exposed to hypertension, but it also must adapt to having lost its mate. Thus, the perfect set-up for vascular and glomerular sclerosis is established.
DR. STEVEN ZELMAN (Renal Fellow, NEMC): Since the glomerular blood flow and glomerular pressures would be increased even if the systemic blood pressure were normal in patients who have a serum creatinine of 4 mgldl, should we perhaps be lowering the blood pressure to subnormal levels so as to further reduce the glomerular pressure, and perhaps to protect these patients to some extent from this added adaptive hypertension? form of acute PSGN do have a better prognosis. Some very good studies, such as those carried out in Trinidad, show that patients with epidemic PSGN do much better than patients with sporadic cases, at least over the first decade. Seven to 12 years was the period covered in the longest follow-up from Trinidad, which was published in 1979 [81] . Because this study included fewer patients with renal functional impairment or even proteinuria or hypertension, I think that epidemic nephritis (at least in Trinidad) is milder than is sporadic nephritis, and that many cases that would not be recognized sporadically are picked up during epidemics; possibly both theories are true. In general, it is acknowledged that during epidemics instances of mild nephritis are detected that otherwise would be missed. However, many of these children in Trinidad did not have mild disease. There must be some other explanation for the better prognosis of epidemic PSGN. For one thing, young people are primarily affected. We know, from our own sporadic cases [82] and the reports of others [83] , that youngsters are affected less severely and that they do better at least over the first 10 to 15 years from onset than do adults. The fact that adults do worse may be related to the greater vulnerability of the aging kidney to glomerular sclerosis. To return to your question, I agree that there is a difference. I really don't know the reason for this difference except that more younger patients with milder disease may have been included in the studies of epidemics. the clinical course of patients with single kidneys who happened to get a form of glomerular disease that was identified? Second, have you followed patients with chronic nephritis who subsequently developed renovascular hypertension? Do such patients have an increase in proteinuria, a finding that would be in accord with your experimental observations? DR. BALDWIN: I don't know of any patients with single kidneys who had morphologically documented acute glomerulonephritis. We would not hazard a renal biopsy in such patients. We have under observation patients with other forms of glomerular disease in whom it was deemed important to get a biopsy, and an open one was obtained because of unilateral renal agenesis. There are too few patients of this kind, however, to say whether they fare worse than do nephritics with two kidneys. I don't know of any of our patients with nephritis who have developed superimposed renovascular hypertension. A few individuals have been described who have renovascular hypertension and the nephrotic syndrome. I have often wondered if they did not perhaps have underlying glomerulonephritis.
